About Dionex
Dionex is a company based in San Francisco (United States) founded in 1975 was acquired by Thermo Fisher Scientific in December 2010. Dionex offers products and services including HPLC Systems, GC Systems, IC Systems, Chromatography Columns, and Chromeleon CDS. Dionex operates in a competitive market with competitors including ChromaTan, Reach Separations, Sepax Technologies, Knauer and Sepragen, among others.
- Headquarter San Francisco, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website dionex.com
- Social LinkedIn
- Acquired by Thermo Fisher Scientific (Dec 2010)
- Legal Name Thermo Fisher Scientific Inc
- Investors
- Acquired byThermo Fisher Scientific
(Dec 2010)
Products & Services of Dionex
Dionex offers a comprehensive portfolio of products and services, including HPLC Systems, GC Systems, IC Systems, Chromatography Columns, and Chromeleon CDS.
Systems for high-performance liquid chromatography analysis in labs.
Gas chromatography systems for sample analysis and separation.
Ion chromatography systems for chemical and environmental testing.
Columns used for separating compounds in chromatography processes.
Data system software for managing chromatography data and compliance.
Investors in Dionex
Dionex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Thermo Fisher Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Electron microscopy services and microanalysis instruments are provided. | 1956 | thermofisher.com | Waltham, United States |
Investor details for Dionex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dionex
14 people are tracked at Dionex (4 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Blain Bowman | Chief Executive Officer | Leadership |
Art Fitchett | Director, North America Sales & Service, Operations And Compliance | Leadership |
Joachim Weiss | Technical Director | Leadership |
Yan Liu | Technical Director | Leadership |
Amarjit Bhasin | LEAD Chemist | Team |
Angela Marcelo | Assistant Accountant | Team |
Rich Kornfeld | Applications Chemist | Team |
Dean Victory | Senior Service Engineer. Ion Chromatography Qualification Specialist. | Team |
Chetan Chavan | Manager Application Support | Team |
Morlan Lunsford | HPLC Specialist, Group Leader | Team |
Paul Siggins | Electrical Engineer | Team |
Peter Kanefsky | Chemist | Team |
Andy Woodruff | Staff Chemist R D | Team |
Linda Parish | Senior Accountant | Team |
Complete people profiles for Dionex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dionex
2 dated milestones of Dionex across 35 years, from founding to its latest funding, stage changes and deals.
- Founded Dionex is founded.
- Exit Acquired by Thermo Fisher Scientific.
Competitors of Dionex
Dionex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Reach Separations, Sepax Technologies, Knauer and Sepragen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromatan.com | 2009 | State College, United States | $5.32M | – | Continuous countercurrent tangential chromatography separation technology is developed. | |
| reachseparations.com | 2011 | Nottingham, United Kingdom | – | 16 | Small molecule analysis and purification services are provided using chromatography. | |
| sepax-tech.com | 2002 | Newark, United States | $109.24M | 57 | Solutions for chromatographic biomolecular separation are developed and provided. | |
| knauer.net | 1962 | Berlin, Germany | – | – | Provides liquid chromatography solutions | |
| sepragen.com | 1987 | Hayward, United States | $5M | 19 | Biomolecular separation technologies are enabled for bioprocessing applications. | |
| biaseparations.com | 1998 | Villach, Austria | $1.69M | 2 | Monolithic chromatographic columns are developed using Convective Interaction Media technology. | |
| sembabio.com | 2005 | Madison, United States | $5.85M | – | Provider of systems for molecular separation based on simulated moving bed chromatography (SMBC) | |
| upfront-dk.com | 1992 | Copenhagen, Denmark | $32.27M | 5 | Chromatography technologies for protein separation and biomolecule recovery are provided. | |
| pharmafluidics.com | 2010 | Ghent, Belgium | – | 14 | Microchip liquid chromatography cartridges are supplied for nano-LC applications. | |
| indigobio.com | 2004 | Indianapolis, United States | $12.35M | 27 | Laboratory automation software is developed by Indigo BioAutomation. |
Detailed competitors of Dionex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Dionex
Websites that share an audience with Dionex (dionex.com).
Websites whose visitors overlap most with Dionex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| upfront-dk.com | 100% | 1.2K | #14,647,117 | View details | |
| armen-instrument.com | 100% | – | – | View details | |
| seal-analytical.com | 99% | 7.6K | #2,872,927 | View details | |
| waters.com | 98% | 416.8K | #124,184 | View details | |
| biocryst.com | 96% | 16.2K | #1,533,322 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 12 similar websites and full traffic analytics for Dionex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Dionex
Complete news archive for Dionex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Dionex
10 companies that operate in the same segment as Dionex (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dionex
Dionex was founded in 1975.
Dionex is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Dionex was founded in 1975 in San Francisco, United States, focusing on chromatography and extraction technologies. Ion chromatography, liquid chromatography, automated sample preparation, and related software are included in its product portfolio. Services are extended to sectors such as life sciences, chemicals, petrochemicals, food safety, electronics, power, and biofuels. The company was acquired by Thermo Fisher Scientific in December 2010, integrating its operations into broader scientific instrumentation.
Dionex's top competitors include ChromaTan, Sepragen and Sepax Technologies.
Dionex offers HPLC Systems, GC Systems, IC Systems, Chromatography Columns, and Chromeleon CDS.
Dionex has 1 investor. Key investors include Thermo Fisher Scientific.
Dionex operates through Thermo Fisher Scientific Inc.
Yes. Dionex was acquired by Thermo Fisher Scientific in December 2010.

